An international team has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells.
A valuable cache of brain cancer biomedical data, termed REMBRANDT, has been made freely accessible to researchers worldwide.
A proof-of-concept study reveals that silibinin may reduce brain metastasis in mice and patients, providing a potential treatment option for secondary brain tumors.
For World Brain Tumor Day (8 June), Gene Barnett, a neurosurgeon at the Cleveland Clinic (OH, USA) discusses common perceptions around brain tumors and their work with ‘tumor-treating fields’.
Interim results from a Phase III trial of DCVax®-L have revealed that the vaccine could be safe in glioblastoma patients and may extend survival.
This week, our industry report covers neuroblastoma, DUB inhibitors for neurodegenerative diseases and pediatric multiple sclerosis.
In partnership with The Brain Tumour Charity, the Cancer Research UK Brain Tumour Awards hope to tackle six major themes in brain tumor research.
New research suggests Huntington’s disease may provide protection from cancer.
From novel biomarkers, to the potential use of the Zika virus as a tumor treatment, read our round-up of the biggest neuro-oncology news from the last year as we mark World Cancer Day.
The aim of this study was to examine the possible correlation between IGF-I levels in serum in large vestibular schwannomas and its potential neuroprotective effect on the vestibulocochlear nerve.